Geneva, Aug. 6 -- International Clinical Trials Registry received information related to the study (NCT07738068) titled 'Progesterone Luteal Support in Unexplained Infertility Management' on July 22.
Study Type: Interventional
Study Design:
Allocation: Randomized. Intervention model: Parallel Assignment. Primary purpose: Treatment. Masking: Triple (Participant, Care Provider, Investigator).
Primary Sponsor: Simone Broer
Condition:
Infertility
Female Infertility
Subfertility
Infertility Primary
Infertility Secondary
Subfertility, Female
Intervention:
Drug: Utrogestan(R) 200 mg Soft Capsule
Recruitment Status: Not recruiting
Phase: Phase 3
Date of First Enrollment: August 1, 2026
Target Sample Size: 640
To know more, visit ...